Omegaven is an intravenous fat emulsion (IFE) comprised of omega-3 fatty acids derived from
fish oil. It will be used in an open label compassionate use treatment protocol, as an
alternative to soybean oil (omega-6), as the sole IFE source of parenteral nutrition in an
effort to reduce and/or reverse parenteral nutrition associated liver disease. The study will
evaluate the safety and efficacy of Omegaven use in pediatric patients with PN dependence and
PNALD.
Details
Lead Sponsor:
St. Luke's Health System, Boise, Idaho St. Luke’s Health System, Boise, Idaho